Arts, entertainment, film, festivals and more events happening this week in the greater Capital Region from Thursday, Jan. 8, ...

Schrodinger said on Friday it is collaborating with Eli Lilly to offer the pharmaceutical major's AI-based platform, TuneLab, ...

Schrödinger (SDGR) stock and Revvity (RVTY stock are in focus as firms join Eli Lilly (LLY) to integrate their software with ...

Variant Bio, a private biotech firm, said on Tuesday it has launched a platform that uses artificial intelligence on genetic ...

MIT researchers are now turning the prolific Boltz series of models into a software company that promotes open science for AI-guided therapeutics.

aims to advance oncology research by integrating computational design, medicinal chemistry, biology, medical science and ...

JUPITER — Using a blend of computer modeling, structural and cell-based studies, scientists at The Wertheim UF Scripps ...

This essay is part of a First Opinion series on the future of the National Institutes of Health and American science. Around the world, nations with robust research and development infrastructure race ...

Less than six months after a series A fundraise, AI drug developer Chai Discovery has brewed up a $130 million series B to further energize development of its “computer-aided design suite” for new ...

Co-founded by Jennifer Doudna and Fyodor Urnov, the company intends to simultaneously develop many gene editing treatments ...